NovaBridge Biosciences (Nasdaq: NBP), an SEC filer in Pharmaceutical Preparations, closed at $1.89, +1.1%, on 2026-08-27, with a return on equity of -21.4%. Institutional ownership, earnings history and filed financials are on the tabs below.
The 200-day average draws at 200 bars — this window holds 197.
Returns use ADJUSTED closes (splits + dividends).
Volume as VALUE TRADED — close × volume, in USD.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | NBP | SPY | Δ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 · ytd | −16.8% | −0.9% | −25.0% | +0.4% | −28.3% | +10.2% | −17.9% | +18.1% | — | — | — | — | −52.5% | +13.4% | −65.9pp |
| 2025 · part | — | — | — | — | — | — | — | — | — | — | −22.4% | +3.6% | −19.6% | +17.7% | −37.3pp |
Month-end over prior month-end; a blank cell is no return.
Basis. Both columns share one basis, so Δ is like-for-like.
End-of-day closes; a “ytd” or “part” year is not a full year.
| Month | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Years ⓘ | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | — | — | 1 | 1 |
| Positive ⓘ | 0% | 0% | 0% | 100% | 0% | 100% | 0% | 100% | — | — | 0% | 100% |
| Median | −16.8% | −0.9% | −25.0% | +0.4% | −28.3% | +10.2% | −17.9% | +18.1% | — | — | −22.4% | +3.6% |
| Best | −16.8% | −0.9% | −25.0% | +0.4% | −28.3% | +10.2% | −17.9% | +18.1% | — | — | −22.4% | +3.6% |
| Worst | −16.8% | −0.9% | −25.0% | +0.4% | −28.3% | +10.2% | −17.9% | +18.1% | — | — | −22.4% | +3.6% |
| vs SPY ⓘ | −18.3pp | −0.0pp | −20.1pp | −10.1pp | −33.6pp | +11.2pp | −18.0pp | +15.1pp | — | — | −22.6pp | +3.6pp |
10 monthly observations · 2025–2026 · benchmark SPY
